Literature DB >> 31965259

Pseudo-continuous arterial spin labelling shows high diagnostic performance in the detection of postoperative residual lesion in hyper-vascularised adult brain tumours.

Clara Cohen1, Bruno Law-Ye2, Didier Dormont2,3, Delphine Leclercq2, Laurent Capelle4, Marc Sanson5, Damien Galanaud2,3, Nadya Pyatigorskaya2,3.   

Abstract

OBJECTIVES: Our aim was to evaluate the contribution of pseudo-continuous arterial spin labelling (pCASL) in the detection of a postoperative residual lesion in adult brain tumours.
METHODS: Seventy-five patients were prospectively included. Following the results of preoperative DSC-PWI assessment, intra-axial lesions, including high-grade gliomas (n = 43) and certain metastases (n = 14), were classified as hyper-vascular (HV+ group, n = 57); other lesions, including low-grade gliomas and certain metastases, were classified as non-hyper-vascular (HV- group, n = 18). To confirm the absence/presence of a residual lesion or disease progression, postoperative MRI including pCASL sequence and follow-up-MRI were performed within 72 h and 1-6 months after the resection, respectively. Two raters evaluated the images. Mean and maximal ASL cerebral blood flow (CBF) values were measured in the perioperative region and normalised to the contralateral tissue. The pCASL-CBF maps and post-contrast T1WI were visually assessed for residual lesion. Quantitative data were analysed with unpaired Student t and Mann-Whitney U tests and the visual diagnostic performance with the McNemar test.
RESULTS: In the HV+ group, the mean normalised CBF was 1.97 ± 0.59 and 0.97 ± 0.29 (p < 0.0001, AUC = 0.964, cut-off = 1.27) for patients with or without residual tumours, respectively. The mean normalised CBF was not discriminative for assessing residual tumours in the HV- group (p = 0.454). Visual CBF evaluation allowed 92.98% patients belonging to the HV+ group to be correctly classified (sensitivity 93.02%, specificity 92.86%, p < 0.001). Visual evaluation was correlated with contrast enhancement evaluation and with the mean normalised CBF values (r = 0.505, p < 0.0001 and 0.838, p < 0.0001, respectively).
CONCLUSION: Qualitative and quantitative ASL evaluation shows high diagnostic performance in postoperative assessment of hyper-perfused tumours. In this case, postoperative pCASL may be useful, especially if contrast injection cannot be performed or when contrast enhancement is doubtful. KEY POINTS: • Evaluation of postoperative residual lesion in the case of brain tumours is an imaging challenge. • This prospective monocentric study showed that increased normalised cerebral blood flow assessed by pseudo-continuous arterial spin labelling (pCASL) correlates well with the presence of a residual tumour in the case of hyper-vascular tumour diagnosed on preoperative MRI. • Qualitative and quantitative pCASL is an informative sequence for hyper-vascular residual tumour, especially if acquired more than 48 h after brain tumour surgery, when contrast enhancement can give ambiguous results due to blood-brain barrier disruption.

Entities:  

Keywords:  Brain tumours; Magnetic resonance imaging; Perfusion imaging; Postoperative procedures; Residual tumour

Mesh:

Substances:

Year:  2020        PMID: 31965259     DOI: 10.1007/s00330-019-06474-4

Source DB:  PubMed          Journal:  Eur Radiol        ISSN: 0938-7994            Impact factor:   5.315


  50 in total

Review 1.  The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary.

Authors:  David N Louis; Arie Perry; Guido Reifenberger; Andreas von Deimling; Dominique Figarella-Branger; Webster K Cavenee; Hiroko Ohgaki; Otmar D Wiestler; Paul Kleihues; David W Ellison
Journal:  Acta Neuropathol       Date:  2016-05-09       Impact factor: 17.088

Review 2.  Primary brain tumours in adults.

Authors:  Damien Ricard; Ahmed Idbaih; François Ducray; Marion Lahutte; Khê Hoang-Xuan; Jean-Yves Delattre
Journal:  Lancet       Date:  2012-04-16       Impact factor: 79.321

3.  Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas.

Authors:  T Sugahara; Y Korogi; M Kochi; I Ikushima; T Hirai; T Okuda; Y Shigematsu; L Liang; Y Ge; Y Ushio; M Takahashi
Journal:  AJR Am J Roentgenol       Date:  1998-12       Impact factor: 3.959

4.  Residual tumor volume versus extent of resection: predictors of survival after surgery for glioblastoma.

Authors:  Matthew M Grabowski; Pablo F Recinos; Amy S Nowacki; Jason L Schroeder; Lilyana Angelov; Gene H Barnett; Michael A Vogelbaum
Journal:  J Neurosurg       Date:  2014-09-05       Impact factor: 5.115

5.  Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based study.

Authors:  Daniel N Cagney; Allison M Martin; Paul J Catalano; Amanda J Redig; Nancy U Lin; Eudocia Q Lee; Patrick Y Wen; Ian F Dunn; Wenya Linda Bi; Stephanie E Weiss; Daphne A Haas-Kogan; Brian M Alexander; Ayal A Aizer
Journal:  Neuro Oncol       Date:  2017-10-19       Impact factor: 12.300

6.  Uninterpretable Dynamic Susceptibility Contrast-Enhanced Perfusion MR Images in Patients with Post-Treatment Glioblastomas: Cross-Validation of Alternative Imaging Options.

Authors:  Young Jin Heo; Ho Sung Kim; Ji Eun Park; Choong-Gon Choi; Sang Joon Kim
Journal:  PLoS One       Date:  2015-08-21       Impact factor: 3.240

7.  Combination of IVIM-DWI and 3D-ASL for differentiating true progression from pseudoprogression of Glioblastoma multiforme after concurrent chemoradiotherapy: study protocol of a prospective diagnostic trial.

Authors:  Zhi-Cheng Liu; Lin-Feng Yan; Yu-Chuan Hu; Ying-Zhi Sun; Qiang Tian; Hai-Yan Nan; Ying Yu; Qian Sun; Wen Wang; Guang-Bin Cui
Journal:  BMC Med Imaging       Date:  2017-02-01       Impact factor: 1.930

8.  Glioma imaging in Europe: A survey of 220 centres and recommendations for best clinical practice.

Authors:  S C Thust; S Heiland; A Falini; H R Jäger; A D Waldman; P C Sundgren; C Godi; V K Katsaros; A Ramos; N Bargallo; M W Vernooij; T Yousry; M Bendszus; M Smits
Journal:  Eur Radiol       Date:  2018-03-13       Impact factor: 5.315

9.  Differentiation of glioblastoma multiforme, metastases and primary central nervous system lymphomas using multiparametric perfusion and diffusion MR imaging of a tumor core and a peritumoral zone-Searching for a practical approach.

Authors:  Małgorzata Neska-Matuszewska; Joanna Bladowska; Marek Sąsiadek; Anna Zimny
Journal:  PLoS One       Date:  2018-01-17       Impact factor: 3.240

10.  A comparison of arterial spin labeling and dynamic susceptibility perfusion imaging for resection control in glioblastoma surgery.

Authors:  Thomas Lindner; Hajrullah Ahmeti; Julia Juhasz; Michael Helle; Olav Jansen; Michael Synowitz; Stephan Ulmer
Journal:  Oncotarget       Date:  2018-04-06
View more
  1 in total

1.  Two Novel Intronic Mutations in the CSF1R Gene in Two Families With CSF1R-Microglial Encephalopathy.

Authors:  Jiwei Jiang; Wenyi Li; Xiaohong Wang; Zhongli Du; Jinlong Chen; Yaou Liu; Wei Li; Zhonghua Lu; Yanli Wang; Jun Xu
Journal:  Front Cell Dev Biol       Date:  2022-05-24
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.